About
Abasi Ene-Obong is the founder and CEO of Syndicate Bio, a health technology company developing diverse human health datasets and applying AI/ML to health research and care. He previously founded and served as CEO of 54gene, an African genomics company where he built a biobank of over 100,000 consented samples linked to clinical records, and worked as a management consultant at IQVIA and PwC advising pharmaceutical companies. He holds a PhD in Cancer Biology from the University of London, an MSc in Human Molecular Genetics from Imperial College London, and a business master's from the Keck Graduate Institute, and has been published in journals including Cell, Nature, and Cancer Discovery.
Founder at 54GeneYC W19
Intro paths
YC
Abasi went through Y Combinator (Winter 2019) — any YC alum in your network can reach them through the YC community.
→
In turn, Abasi can intro founders to 54Gene's investors below.
54Gene's investors · 6
Co-founders at 54Gene
GA
Gatumi AliyuFounder
OF
Ogochukwu Francis OsifoFounder
Experience
- Syndicate BioFounder and CEOcurrent2023 — present
- ACMG - American College of Medical Genetics and GenomicsMember, International Outreach and Engagement Committeecurrent2024 — present
- Society for Family Health NigeriaMember Board of Trusteescurrent2022 — present
- BloombergMember, Bloomberg New Economy Forum International Cancer Coalitioncurrent2022 — present
- 54geneFounder and CEO2019 — 2022
- Pathfinder InternationalLead Consultant (state) - Nigeria's Strategic Health Development Plan2017Nigeria
- PwCSenior Associate, Health Industries Advisory2015 — 2016Greater Chicago Area
- IMS HealthConsultant2014 — 2015Greater Philadelphia
- IMS HealthResearch Manager, IMS Institute for Healthcare Informatics2014
- Gilead SciencesConsultant2013 — 2014Los Angeles Metropolitan Area
- PanasonicStrategy Consultant2013
- Barts Cancer InstituteDoctoral Researcher2010 — 2013London Area, United Kingdom
- Institute of Psychiatry, King's College LondonHonorary Research Associate2009 — 2010London Area, United Kingdom
Skills & more
Startups8Life Sciences31Business Development10Molecular Biology29Entrepreneurship13Genetics7Marketing Strategy7Market Research7Project Management6Cancer7Consulting5Genomics5
+12 more
Drug DiscoveryManagement ConsultingBusiness StrategyBusiness Process DesignMedical DevicesProduct DevelopmentMarketing ManagementProduct marketingStrategyManagementLeadershipPharmaceutical IndustryLanguages English · French · Igbo
From Abasi's professional profile.
Frequently asked questions
- Who is Abasi Ene-Obong?
- Abasi Ene-Obong is the founder and CEO of Syndicate Bio, a health technology company developing diverse human health datasets and applying AI/ML to health research and care. He previously founded and served as CEO of 54gene, an African genomics company where he built a biobank of over 100,000 consented samples linked to clinical records, and worked as a management consultant at IQVIA and PwC advising pharmaceutical companies. He holds a PhD in Cancer Biology from the University of London, an MSc in Human Molecular Genetics from Imperial College London, and a business master's from the Keck Graduate Institute, and has been published in journals including Cell, Nature, and Cancer Discovery.
- Where does Abasi Ene-Obong work?
- Abasi Ene-Obong is Founder of 54Gene.
- What companies did Abasi Ene-Obong found?
- Abasi Ene-Obong founded 54Gene.
- Where did Abasi Ene-Obong go to school?
- Abasi Ene-Obong studied at Imperial College London (Master of Science (M.Sc.); DIC, Human Molecular Genetics); Keck Graduate Institute (Masters of Business and Management, Bioscience management); University of London (PhD- Barts and the London School of Medicine and Dentistry, Cancer Biology).
Same school
Also attended Imperial College London643
Deji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMadison LenormandInvestor at DaphniLoubaba El AyoubiInvestor at NorthzoneGiovanni MariggiInvestor at MedicxiFrancois PrinslooInvestor at MedicxiBen PerryInvestor at Medicxi
+ 637 more
Also attended Keck Graduate Institute8
Seth LieblichInvestment Team at 8VCMira ChaurushiyaManaging Director at Westlake Village BioPartnersMary GuanInvestor at Sand Hill AngelsKavya TallapakaConsulting at Rock HealthAdar Makovski SilversteinPrincipal at Arkin CapitalCurt HerbertsInvestor at Premji Invest
+ 2 more
Also attended University of London137
Sandra SchwarzerInvestor at Index VenturesAnneleen PeetersNon-executive Director at Capricorn Venture PartnersKarim GillaniGeneral Partner at Luge CapitalRoxanneCompliance Officer at Hummingbird VenturesRakesh MurriaCOO at Nauta CapitalJos WhiteGeneral Partner at Notion Capital
+ 131 more
Also attended Y Combinator2,000
Tarek MansourCo-founder & CEO of KalshiSuhail DoshiFounder of Mixpanel; founder of ParticleSubomi OluwalanaCo-founder & CEO of ConvoyArhaan A.Deeptech Fellow at Clear VenturesMaroof AhmedFounder at Octopus VenturesCollin WallaceGeneral Partner at Lobby Capital
+ 1,994 more
Shared employers
Also worked at Syndicate Bio1
Also worked at Bloomberg194
Reed HastingsCo-founder of NetflixEric WagnerVP of Research and Data at Redpoint VenturesVivek GopalanInvestment Team at 8VCAndrea GurnariInvestor at Moonfire VenturesSarika Temme-BapatVenture Operations Associate at Mission BiocapitalAllison PavlickInvestor Relations Principal at S32
+ 188 more
